Generic Name: Generic evista
What is Generic Evista?
Nearly 3,000 transvaginal ultrasound TVUs examinations were evaluated from 831 women in all dose groups. Raloxifene treated women consistently had an endometrial thickness which was indistinguishable from placebo. After 3 years of treatment, at least a 5 mm increase in endometrial thickness, assessed with transvaginal ultrasound, was observed in 1. There were no differences between the raloxifene and placebo groups with respect to the incidence of reported uterine bleeding.
Endometrial biopsies taken after six months therapy with Evista 60 mg daily demonstrated non-proliferative endometrium in all patients. In addition, in a study with 2. In the osteoporosis treatment trial, endometrial thickness was evaluated annually in a subset of the study population 1,644 patients for 4 years. Endometrial thickness measurements in Evista treated women were not different from baseline after 4 years of therapy. There was no difference between Evista and placebo treated women in the incidences of vaginal bleeding spotting or vaginal discharge.
Fewer Evista treated women than placebo treated women required surgical intervention for uterine prolapse.
EmpowHER does not provide medical advice, diagnosis, or treatment. View more info This site complies with the HONcode standard for trustworthy health information: verify here. Hogyan hat az Evista. Hogyan kell szedni az Evista-t. Minden filmtabletta 60 mg raloxifen- hidrokloridot tartalmaz, mely 56 mg raloxifennek felel meg. Raloxifene hydrochloride trade name Evista is very new anti-estrogenic drug on the prescription market, and it is a member of the category of drugs known as selective estrogen receptor modulators SERMswhich is actually a sub-category of an even broader category of drugs known as anti-estrogens.
Additionally, SERMs can and do act as Estrogen agonists in other tissues in the body namely, in the liver. As an Estrogen agonist, the drug will serve to do the opposite of the previously described action, and instead it will bind to the receptor and initiate estrogenic effects in those tissues.
As a result, SERMs serve to only antagonize or agonize the effects of Estrogen in certain tissues - they will not reduce total circulating blood plasma levels of Estrogen in the body, and therefore some estrogenic side effects cannot be remedied by SERMs, such as water retention and bloating.
Specifically, Raloxifene is a non-steroidal SERM belonging to the benzothiophene family. Raloxifene is very similar in its mode of action as Nolvadex Tamoxifenand does exhibit both Estrogen agonist as well as Estrogen antagonist effects in different tissues throughout the body. In particular, Raloxifene serves as an Estrogen antagonist in breast tissue and uterine tissue while at the same time acting as an Estrogen agonist in bone tissue. Raloxifene is in fact utilized in medicine in the prevention of osteoporosis in post-menopausal females due to its estrogenic activity in bone.
How should I take Generic Evista?
Placebo-Controlled Osteoporosis Prevention Clinical Trials - The safety of raloxifene has been assessed primarily in 12 Phase 2 and Phase 3 studies with placebo, estrogen, and estrogen-progestin therapy control groups.
Comparison of EVISTA and Hormone Therapy - EVISTA was compared with estrogen-progestin therapy in three clinical trials for prevention of osteoporosis. Breast Pain - Across all placebo-controlled trials, EVISTA was indistinguishable from placebo with regard to frequency and severity of breast pain and tenderness. Gynecologic Cancers - EVISTA-treated and placebo-treated groups had similar incidences of endometrial cancer and ovarian cancer.
Raloxifene HCl is an off-white to pale-yellow solid that is very slightly soluble in water. Absorption - Raloxifene is absorbed rapidly after oral administration.
What should I avoid while taking Generic Evista?
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:An interaction between two medications does not always mean that you must stop taking one of them.
Speak to your doctor about how any drug interactions are being managed or should be managed. Medications other than those listed above may interact with this medication. Tell your doctor or prescriber about all prescription, over-the-counter non-prescriptionand herbal medications you are taking.
Also tell them about any supplements you take. Since caffeine, alcohol, the nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
All material copyright MediResource Inc.
Generic Evista side effects
However, if it is almost time for your next dose, skip the missed dose and take only your next regularly scheduled dose. Do not take two doses at the same time. What should I avoid while taking EVISTA.
Being still for a long time such as during long trips or being in bed after surgery can increase the risk of blood clots. EVISTA may add to this risk. If you will need to be still for a long time, talk with your doctor about ways to reduce the risk of blood clots. On long trips, move around periodically. Stop taking EVISTA at least 3 days before a planned surgery or before you plan on being still for a long time.
Common Generic Evista ide effects may include:
Paediatric population: Evista should not be used in children of any age.
If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.
These effects of raloxifene were reversible.
Mutagenesis - Raloxifene HCl was not genotoxic in any of the following test systems: the Ames test for bacterial mutagenesis with and without metabolic activation, the unscheduled DNA synthesis assay in rat hepatocytes, the mouse lymphoma assay for mammalian cell mutation, the chromosomal aberration assay in Chinese hamster ovary cells, the in vivo sister chromatid exchange assay in Chinese hamsters, and the in vivo micronucleus test in mice.
Estrogen is instrumental in building healthy bone tissue because it helps the body absorb calcium and phosphates, both essential bone making ingredients. Evista works like a designer estrogen - it cleverly provides estrogen to the bones, so they become stronger but at the same time avoids producing an estrogen effect on the breasts and uterus. This is important because excessive estrogen may be one of the causes of breast cancer and uterine cancer.
Where can I get more information?
Safety of EVISTA in premenopausal women has not been established and its use is not recommended.
Any doctor or surgeon who treats you should know that you are taking this medicine.